Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide

Authors

Rebecca F. Carlin, Greater Baltimore Medical Center (GBMC)

Document Type

Article

Publication Title

Journal of Clinical Oncology

First Page

3723

Last Page

3728

DOI

https://doi.org/10.1200/jco.2013.51.2913

Publication Date

11-20-2014

Recommended Citation

Roboz GJ, Ritchie EK, Carlin RF, Samuel M, Gale L, Provenzano-Gober JL, Curcio TJ, Feldman EJ, Kligfield PD. Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide. J Clin Oncol. 2014 Nov 20;32(33):3723-8. doi: 10.1200/JCO.2013.51.2913. Epub 2014 Sep 22. PMID: 25245447.